共 107 条
[1]
Zheng Z(2017)Ethical Off-label Drug use: Need for a Rethink? Indian Pediatr 54 447-450
[2]
Yang M(2008)Defining off-label and unlicensed use of medicines for children: results of a Delphi survey Pharmacol Res 58 316-322
[3]
Wu J(2014)Safety of medical interventions in children versus adults Pediatrics 133 e666-e673
[4]
Neubert A(2008)Prioritizing future research on off-label prescribing: results of a quantitative evaluation Pharmacotherapy 28 1443-1452
[5]
Wong IC(2009)Going off-label without venturing off-course: evidence and ethical off-label prescribing Arch Intern Med 169 1745-1747
[6]
Bonifazi A(2020)COVID-19 and off label use of drugs: an ethical viewpoint Daru 28 789-793
[7]
Lathyris D(2020)Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics JAMA 323 1897-1898
[8]
Panagiotou OA(2020)Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection CMAJ 192 E450-E453
[9]
Baltogianni M(2020)ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic J Med Toxicol 16 342-345
[10]
Ioannidis JP(2012)Japanese regulatory system for approval of off-label drug use: evaluation of safety and effectiveness in literature-based applications Clin Ther 34 2104-2116